Cargando…
_version_ 1782171753910370304
author Chua, Daniel
Fasching, Peter
Ma, Brigette
Thongprasert, Sumitra
Wirth, Lori
author_facet Chua, Daniel
Fasching, Peter
Ma, Brigette
Thongprasert, Sumitra
Wirth, Lori
author_sort Chua, Daniel
collection PubMed
description
format Text
id pubmed-2740841
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-27408412009-09-10 Update on Anti-EGFR Therapy Chua, Daniel Fasching, Peter Ma, Brigette Thongprasert, Sumitra Wirth, Lori J Oncol Editorial Hindawi Publishing Corporation 2009 2009-09-10 /pmc/articles/PMC2740841/ /pubmed/19750187 http://dx.doi.org/10.1155/2009/157964 Text en Copyright © 2009 Daniel Chua et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Chua, Daniel
Fasching, Peter
Ma, Brigette
Thongprasert, Sumitra
Wirth, Lori
Update on Anti-EGFR Therapy
title Update on Anti-EGFR Therapy
title_full Update on Anti-EGFR Therapy
title_fullStr Update on Anti-EGFR Therapy
title_full_unstemmed Update on Anti-EGFR Therapy
title_short Update on Anti-EGFR Therapy
title_sort update on anti-egfr therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740841/
https://www.ncbi.nlm.nih.gov/pubmed/19750187
http://dx.doi.org/10.1155/2009/157964
work_keys_str_mv AT chuadaniel updateonantiegfrtherapy
AT faschingpeter updateonantiegfrtherapy
AT mabrigette updateonantiegfrtherapy
AT thongprasertsumitra updateonantiegfrtherapy
AT wirthlori updateonantiegfrtherapy